List of NSE Nifty Pharma Index Stocks

List of NSE Nifty Pharma Index Stocks of 2021



Viewing each stock as well as examining its technical then fundamental is a boring process. Our area will certainly give you the high-level review of NSE Nifty Pharma Index stocks of 2021 at one place to take simplified choices for the investments. NSE Nifty Pharma represents on top businesses based on comprehensive market capitalization from Indian stock market. The holdings to NSE Nifty Pharma is calculated based on free float market capitalization stocks weightage.

I’m gonna emphasize up to NSE (National Stock Exchange of India Ltd) is on biggest stock exchange in India typically looks authorized because of the Securities and exchange board of India (SEBI). On NSE was ones trusted eleventh greatest stock exchange in the world by just market capitalization to during $2.036 trillion with month-to-month $196 billion trade amount. NSE started in 1992 plus oversees conformity simply by exchanging furthermore clearing subscribers because of the SEBI rules as well as rules. There tend to be approximately sixteen inside seventeen stock exchanges in the world through USD $1 trillion market capitalization. NSE happens to be commonly named all “$1 Trillion Club Stock Exchange” worldwide.

List of NSE Nifty Pharma Index Stocks of 2021

We all want to choose great stocks, however examining process needs to be used to find the appropriate stock. The following is ones stock screener who will guide one in your screening process. Around areas as well as market caps, we provide you with a a number of Nifty Pharma stocks from 6500+ stocks in order to make your winning profile.

Sr Company Name ISIN Number Listed On Series Group Face Value Listing Date Industry / Company Sector Market Cap (Cr) P/BV 1-Yr Return 1-Yr Profit Growth 3-Yrs Profit Growth 5-Yrs Profit Growth 52 Week High 52 Week High Date 52 Week Low 52 Week Low Date
1 Alkem Laboratories Ltd INE540L01014 NSE & BSE EQ A ₹2.00 23-12-2015 Biotechnology & Drugs ₹34,875.91 4.98 46.37% 57.48% 8.22% 25.92% ₹3,090.00 07-Aug-20 ₹1,881.30 23-Mar-20
2 Aurobindo Pharma Ltd. INE406A01037 NSE & BSE EQ A ₹1.00 19-07-2000 Major Drugs ₹53,223.73 2.9 95.24% 19.15% 7.31% 12.48% ₹967.50 10-Aug-20 ₹288.85 23-Mar-20
3 Biocon Ltd. INE376G01013 NSE & BSE EQ A ₹5.00 07-04-2004 Biotechnology & Drugs ₹55,896.00 7.92 59.66% -17.69% 5.87% 13.01% ₹487.75 23-Dec-20 ₹235.55 19-Mar-20
4 Cadila Healthcare Ltd. INE010B01027 NSE & BSE EQ A ₹1.00 18-04-2000 Biotechnology & Drugs ₹49,927.93 4.25 90.99% 25.96% -1.18% 4.16% ₹491.70 24-Dec-20 ₹202.00 13-Mar-20
5 Cipla Ltd. INE059A01026 NSE & BSE EQ A ₹2.00 08-02-1995 Biotechnology & Drugs ₹66,947.88 3.92 72.97% 12.59% 14.51% 3.43% ₹834.90 24-Dec-20 ₹355.30 13-Mar-20
6 Divi’s Laboratories Ltd. INE361B01024 NSE & BSE EQ A ₹2.00 12-03-2003 Biotechnology & Drugs ₹99,975.47 12.01 103.66% 34.21% 8.83% 9.81% ₹3,859.00 18-Dec-20 ₹1,626.00 13-Mar-20
7 Dr.Reddy’s Laboratories Ltd. INE089A01023 NSE & BSE EQ A ₹5.00 30-05-2003 Biotechnology & Drugs ₹86,505.06 5.19 80.06% -41.25% 17.48% -2.39% ₹5,512.65 21-Sep-20 ₹2,495.05 19-Mar-20
8 Lupin Ltd. INE326A01037 NSE & BSE EQ A ₹2.00 10-09-2001 Biotechnology & Drugs ₹44,614.39 3.51 27.78% -598.51% ₹1,122.30 18-Sep-20 ₹504.75 13-Mar-20
9 Sun Pharmaceutical Industries Ltd. INE044A01036 NSE & BSE EQ A ₹1.00 08-02-1995 Biotechnology & Drugs ₹1,40,828.97 3.12 36.45% -4.18% -17.74% -4.65% ₹595.00 24-Dec-20 ₹312.00 30-Mar-20
10 Torrent Pharmaceuticals Ltd. INE685A01028 NSE & BSE EQ A ₹5.00 25-11-2002 Biotechnology & Drugs ₹47,300.37 8.55 50.61% 41.04% 4.43% 6.26% ₹3,031.20 11-Aug-20 ₹1,583.25 19-Mar-20

NSE Nifty Pharma Stock Examples

Assume that you have invested ₹1,30,000 in Alkem Laboratories Limited (ALKEM) stock listed on 23-Dec-2015 and belonging to Pharmaceuticals sector for 1 year. Alkem Laboratories Ltd stock has given annual returns of 31% for 1 year. Now calculate Alkem Laboratories Ltd stock growth with Compound annual growth rate (CAGR) formula. Notice that on investment of ₹1,30,000 in Alkem Laboratories Limited (ALKEM), you get ₹1,70,300 as investment returns.

Read More